| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
SpyGlass Pharma, Inc.
13G
SGP · 85220G109
|
7.8% |
2/13/2026
Event 2/6/2026
|
||||
| Sands Capital Life Sciences Pulse Fund III (DE), L.P. | 1.3% | |||||
| Sands Capital Life Sciences Pulse Fund III-Holdings, L.P. | 6.5% | |||||
| Sands Capital Alternatives, LLC | 1.3% | |||||
| Sands Frank M. | 7.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.